Article (Scientific journals)
Sodium-glucose co-transporter type-2 inhibitors for hospitalised patients with COVID-19: safe but not protective.
Scheen, André
2024In The Lancet Diabetes and Endocrinology
Peer Reviewed verified by ORBi
 

Files


Full Text
2024Lancetde Comment.pdf
Author postprint (192.12 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Endocrinology, metabolism & nutrition
Pharmacy, pharmacology & toxicology
Author, co-author :
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques
Language :
English
Title :
Sodium-glucose co-transporter type-2 inhibitors for hospitalised patients with COVID-19: safe but not protective.
Publication date :
05 September 2024
Journal title :
The Lancet Diabetes and Endocrinology
ISSN :
2213-8587
eISSN :
2213-8595
Publisher :
Elsevier, Nl
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 10 October 2024

Statistics


Number of views
15 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0
OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi